Optimized production and concentration of lentiviral vectors containing large inserts. 2007

Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
Department of Dermatology, Charité University Hospital, Berlin, Germany.

Generation of high titer lentiviral stocks and efficient virus concentration are central to maximize the utility of lentiviral technology. Here we evaluate published protocols for lentivirus production on a range of transfer vectors differing in size (7.5-13.2 kb). We present a modified virus production protocol robustly yielding useful titers (up to 10(7)/ml) for a range of different transfer vectors containing packaging inserts up to 7.5 kb. Moreover, we find that virus recovery after concentration by ultracentrifugation depends on the size of the packaged inserts, heavily decreasing for large packaged inserts. We describe a fast (4 h) centrifugation protocol at reduced speed allowing high virus recovery even for large and fragile lentivirus vectors. The protocols outlined in the current report should be useful for many labs interested in producing and concentrating high titer lentiviral stocks.

UI MeSH Term Description Entries
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014461 Ultracentrifugation Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D016086 Lentivirus A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species. Lentivirinae,Lentiviruses

Related Publications

Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
January 2020, Methods in molecular biology (Clifton, N.J.),
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
November 2020, Pharmaceutics,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
February 2003, Physiological genomics,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
September 2004, Molecular therapy : the journal of the American Society of Gene Therapy,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
January 2002, Current topics in microbiology and immunology,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
January 2016, Molecular therapy. Methods & clinical development,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
January 2009, Nature protocols,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
January 2013, Methods in molecular biology (Clifton, N.J.),
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
January 2018, Journal of biological methods,
Nadya al Yacoub, and Malgorzata Romanowska, and Natalie Haritonova, and John Foerster
December 2010, Current gene therapy,
Copied contents to your clipboard!